CARCINOGENESIS
Scope & Guideline
Exploring Innovations in Cancer Treatment and Research
Introduction
Aims and Scopes
- Molecular Mechanisms of Carcinogenesis:
Research exploring the cellular and molecular pathways that lead to cancer development, including genetic mutations, epigenetic changes, and signaling pathways. - Cancer Biology and Microenvironment:
Studies investigating the interactions between cancer cells and their surrounding microenvironment, including the role of tumor-associated macrophages, extracellular vesicles, and stromal cells. - Preventive and Therapeutic Strategies:
Research aimed at developing and evaluating novel preventive measures and therapeutic interventions for various cancer types, including drug efficacy and resistance mechanisms. - Biomarkers and Prognostic Indicators:
Identification and validation of biomarkers for early detection, prognosis, and treatment response in cancer patients, utilizing genomic, transcriptomic, and proteomic approaches. - Environmental and Lifestyle Factors in Cancer Risk:
Investigations into how environmental exposures, dietary habits, and lifestyle choices contribute to cancer risk and progression. - Technological Innovations in Cancer Research:
Application of advanced technologies such as machine learning, bioinformatics, and next-generation sequencing to enhance our understanding of cancer biology.
Trending and Emerging
- Cancer Immunotherapy and Microenvironment Interactions:
There is a rising interest in understanding how the immune microenvironment influences tumor progression and response to therapy, particularly in relation to immune checkpoint inhibitors. - Role of Non-Coding RNAs in Cancer:
Research on long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs) as significant regulators of cancer biology is increasingly prominent, suggesting their potential as therapeutic targets or biomarkers. - Metabolic Reprogramming in Cancer:
Studies exploring how cancer cells alter metabolic pathways to support growth and survival are on the rise, highlighting the importance of metabolism in cancer therapy. - Machine Learning and AI Applications:
The application of machine learning and artificial intelligence to predict cancer outcomes, identify new therapeutic targets, and analyze complex datasets is rapidly increasing. - Personalized Medicine Approaches:
There is a clear trend towards personalized medicine, with research focusing on tailoring treatments based on individual genetic profiles and tumor characteristics. - Impact of Gut Microbiota on Cancer:
Emerging research on the relationship between gut microbiota and cancer development or treatment response is gaining attention, indicating a shift towards understanding the host-microbe interactions.
Declining or Waning
- Traditional Chemotherapy Mechanisms:
Research focused on classical chemotherapy mechanisms and their direct effects on cancer cells is less prevalent, as newer targeted therapies and immunotherapies gain attention. - Single-Agent Drug Studies:
There is a noticeable decrease in studies solely investigating the efficacy of single-agent chemotherapeutics, with a growing preference for combination therapies and multi-target approaches. - Basic Histopathological Studies:
Traditional histopathological analyses without integrating molecular or genetic data seem to be less common, as the field moves towards more comprehensive, multi-omics studies. - Animal Models of Cancer:
While still relevant, the reliance on traditional animal models is decreasing as researchers explore alternative models, including patient-derived xenografts and organoids. - General Epidemiological Studies:
Generic epidemiological studies that do not incorporate molecular or mechanistic insights are becoming less frequent, as the emphasis shifts towards more integrative and translational research.
Similar Journals
CELL RESEARCH
Unveiling the Mysteries of Cellular MechanismsCELL RESEARCH is a premier peer-reviewed journal dedicated to advancing the field of cell biology and molecular biology, published by SpringerNature. With an impressive impact factor and consistently ranking in the Q1 quartile for both cell biology and molecular biology, this journal serves as a pivotal resource for researchers, professionals, and students seeking to explore the latest discoveries and advancements in cellular mechanisms and their implications for health and disease. Since its inception in 1996, CELL RESEARCH has cultivated a distinguished reputation, currently boasting ranks in the top percentile of Scopus categories, reaffirming its influence and relevance to the scientific community. Although it is not an Open Access journal, its rigorous selection process ensures the publication of high-quality articles that contribute significantly to our understanding of life sciences. For those deeply engaged in the realms of biochemistry, genetics, and molecular biology, CELL RESEARCH is an essential conduit of innovative research and critical insights.
EXPERIMENTAL CELL RESEARCH
Pioneering Insights into Cellular DynamicsEXPERIMENTAL CELL RESEARCH is a highly respected journal published by Elsevier Inc, specializing in the dynamic and ever-evolving field of Cell Biology. With an impact factor positioned in the Q2 quartile for 2023, it ranks at the 124th position out of 285 in the Scopus Ranks, indicating a solid reputation among peers in the domains of biochemistry, genetics, and molecular biology. Since its inception in 1950, the journal has contributed significantly to the dissemination of groundbreaking research, providing a platform for studies that explore the nuances of cellular mechanisms, processes, and experimental methodologies. Although the journal currently does not offer open access, its commitment to high-quality, peer-reviewed research continues to attract submissions from leading scientists and scholars across the globe. Researchers, professionals, and students alike will find this journal an invaluable resource for keeping abreast of current developments and innovative breakthroughs in cellular science.
DRUG RESISTANCE UPDATES
Advancing knowledge in the fight against drug resistance.DRUG RESISTANCE UPDATES is a premier academic journal published by Churchill Livingstone, focusing on the critical areas of drug resistance in various diseases including cancer, infectious diseases, and the pharmacological challenges associated with these conditions. With a robust impact factor and a prestigious Q1 ranking across multiple categories such as Cancer Research, Infectious Diseases, and Pharmacology, this journal is recognized for its significant contributions to the field. Since its inception in 1998 and continuing through to 2024, it has become an essential resource for researchers, clinicians, and policy-makers aiming to understand and combat the evolving challenges of drug resistance. Although it is not an open-access publication, it provides vital insights and research findings that are pivotal in influencing treatment strategies and advancing knowledge within the scientific community. For stellar insights backed by rigorous peer review, DRUG RESISTANCE UPDATES should be on the radar of every professional concerned with the intricacies of modern medicine and pharmacology.
CANCER RESEARCH
Shaping the future of cancer research with excellence.Cancer Research, published by the American Association for Cancer Research, is a premier journal in the field of oncology, renowned for its commitment to advancing cancer research since its inception in 1941. With an impressive impact factor reflecting its vital role in the field, this journal consistently ranks in the Q1 quartile for both Cancer Research and Oncology, positioning it among the top 7.5% of journals in these categories. The journal serves as a crucial platform for researchers, professionals, and students to disseminate and gain insights into groundbreaking studies that shape our understanding of cancer biology, prevention, diagnosis, and treatment. While it is not an open-access publication, its rigorous peer-review process ensures that only high-quality research is published, thus maintaining a standard of excellence in the scientific community. With a strong legacy and an ever-expanding influence, Cancer Research continues to be essential for anyone dedicated to the fight against cancer, showcasing cutting-edge research that drives scientific discovery and innovation.
OncoTargets and Therapy
Connecting researchers and clinicians in the fight against cancer.OncoTargets and Therapy is a prestigious, peer-reviewed journal dedicated to the rapid dissemination of research in the fields of oncology and pharmacology. Published by DOVE MEDICAL PRESS LTD in New Zealand since 2008, this journal has embraced the open access model, ensuring that critical cancer-related research is freely accessible to a global audience. With an impressive impact factor reflected by its Q2 ranking in both the Oncology and Pharmacology (medical) categories for 2023, as well as Scopus rankings placing it in the top 91st percentile in pharmacology and the 84th percentile in oncology, OncoTargets and Therapy stands out as a vital resource for researchers, clinicians, and students alike. The journal focuses on therapeutics, novel drug discoveries, and clinical trials, encouraging collaborative efforts to combat cancer effectively. By providing a platform for groundbreaking studies and comprehensive reviews, it plays a crucial role in advancing knowledge and practice in these critical areas of medical science.
World Journal of Gastrointestinal Oncology
Connecting research and practice in gastrointestinal health and cancer.World Journal of Gastrointestinal Oncology, published by BAISHIDENG PUBLISHING GROUP INC, stands as a pivotal resource in the evolving fields of gastroenterology and oncology, particularly focused on the intricate relationship between gastrointestinal disorders and cancer. Established in 2014, the journal continues to publish influential research, boasting a commendable Q2 ranking in both the gastroenterology and oncology categories for 2023, which underscores its importance in these critical medical domains. With a diverse range of topics and studies, it serves as an essential platform for researchers, healthcare professionals, and students aiming to stay informed about the latest advancements and innovations in gastrointestinal oncology. Though currently not classified as open access, the journal's rigorous peer-review process ensures the dissemination of high-quality research that significantly contributes to clinical practice and patient care. Its positioning in the Scopus rankings also highlights its competitive standing within the scientific community, fostering discussions that are crucial for advancing both fields. Explore the latest insights and findings to enhance your understanding and contribute to the ongoing dialogue in gastrointestinal health and oncology.
CANCER INVESTIGATION
Pioneering insights in oncology for a healthier tomorrow.CANCER INVESTIGATION is a distinguished peer-reviewed journal published by Taylor & Francis Inc, dedicated to the advancing field of cancer research and oncology. With an ISSN of 0735-7907 and E-ISSN of 1532-4192, this journal has been a pivotal resource for professionals and researchers since its inception in 1983, continually contributing to the evolving landscape of cancer investigation until its convergence in 2024. CANCER INVESTIGATION boasts noteworthy rankings in 2023, including Q3 in Cancer Research and Q2 in Medicine (miscellaneous), highlighting its relevance and impact in these critical areas. The journal's commitment to disseminating innovative research and comprehensive reviews makes it an essential platform for those engaged in cancer studies and related disciplines. While currently not available as an open-access publication, CANCER INVESTIGATION remains an invaluable tool for understanding the complexities of cancer, offering insights that drive scientific advancements and improve patient outcomes.
Molecular & Cellular Oncology
Connecting researchers to the forefront of oncology.Molecular & Cellular Oncology, published by Taylor & Francis Inc, is a vital academic journal dedicated to the exploration of cancer biology through the lens of molecular and cellular mechanisms. Since its inception in 2014, the journal has played a crucial role in disseminating innovative research findings that address the fundamental aspects of cancer research and molecular medicine. With its current ranking in Scopus placing it in the Q3 quartile for both Cancer Research and Molecular Medicine, the journal provides a platform for groundbreaking studies that push the boundaries of our understanding of oncogenesis and therapeutic interventions. Although the journal operates under a subscription model, its dedication to high-quality peer-reviewed research makes it an essential resource for researchers, professionals, and students aiming to contribute to or stay updated in the rapidly evolving field of oncology. As we approach the culmination of its converged years in 2024, Molecular & Cellular Oncology aims to continue fostering collaborations and insights that advance cancer research on a global scale.
Cancer Drug Resistance
Empowering Research to Conquer Cancer's Resistance Challenges.Cancer Drug Resistance is a premier journal published by OAE PUBLISHING INC, focusing on the critical field of oncology and pharmacology. Since its inception in 2018, the journal has been at the forefront of presenting innovative research aimed at understanding and overcoming drug resistance in cancer therapy. With an impressive impact factor reflected in its Q2 ranking in Cancer Research and a Q1 ranking in Pharmacology (medical) for 2023, Cancer Drug Resistance serves as a vital resource for researchers, clinicians, and students who are dedicated to advancing cancer treatment and improving patient outcomes. The journal's commitment to disseminating high-quality, peer-reviewed articles underscores its importance within the academic and medical communities. While it operates on an open-access model, facilitating widespread distribution and access to crucial research findings, the journal continuously strives to foster dialogue and collaboration among stakeholders in cancer research and pharmacology. Its mission is clear: to shine a light on the evolving challenges and breakthroughs in drug resistance, paving the way for enhanced therapeutic strategies and clinical solutions.
CURRENT CANCER DRUG TARGETS
Empowering researchers to redefine oncology and pharmacology.CURRENT CANCER DRUG TARGETS is a prominent academic journal published by Bentham Science Publishers Ltd, focusing on the critical intersection of cancer research and innovative drug development. Since its inception in 2001, this journal has offered a platform for the dissemination of cutting-edge research aimed at advancing targeted cancer therapies, contributing significantly to the fields of Cancer Research, Drug Discovery, Oncology, and Pharmacology. With a respectable impact factor and consistent ranking in its respective categories, including Q2 in Drug Discovery and Pharmacology, it positions itself as an invaluable resource for researchers, clinicians, and students alike. CURRENT CANCER DRUG TARGETS is dedicated to enhancing our understanding of novel therapeutic targets and methods, thereby fostering a collaborative environment for knowledge exchange in the ever-evolving landscape of cancer treatment.